Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer


Eroglu C., ORHAN O., Ünal D., Dogu G. G., Karaca H., Dikilitas M., ...More

ANNALS OF THORACIC MEDICINE, vol.8, no.2, pp.109-115, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.4103/1817-1737.109824
  • Journal Name: ANNALS OF THORACIC MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.109-115
  • Keywords: Cisplatin, concomitant chemoradiotherapy, docetaxel, non-small cell lung cancer, CONCURRENT THORACIC RADIOTHERAPY, LEUKEMIA GROUP-B, SOUTHWEST-ONCOLOGY-GROUP, PHASE-III TRIAL, RADIATION-THERAPY, RANDOMIZED-TRIAL, STAGE IIIB, CHEMORADIATION THERAPY, PROGNOSTIC-FACTORS, COMBINATION
  • Erciyes University Affiliated: Yes

Abstract

OBJECTIVES: To evaluate treatment results and toxicities in patients who received concomitant chemoradiotherapy (CRT) followed by consolidation with docetaxel and cisplatin in locally advanced unresectable non-small cell lung cancer (NSCLC).